Clinical Study on Reduced-Dose Pertussis Vaccine in Thailand In collaboration with Faculty of Medicine, Chulalongkorn University, BioNet has advanced a clinical study on a next-generation pertussis vaccine, featuring a reduced-dose recombinant acellular pertussis formulation—from 5 μg to 2 μg while maintaining…